A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE

References

Page 1

	Year	Citations
Radiolabeled somatostatin receptor antagonists are preferable to agonists for<i>in vivo</i>peptide receptor targeting of tumors Mihaela Ginj, Hanwen Zhang, Beatrice Waser, Proceedings of the National Academy of Sciences EngineeringImmunologyPeptide SciencePharmacotherapyPeptide Therapeutics	2006	488
Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study Damian Wild, Melpomeni Fani, Richard Fischer, Journal of Nuclear Medicine	2014	255
PET of Somatostatin Receptor–Positive Tumors Using <sup>64</sup>Cu- and <sup>68</sup>Ga-Somatostatin Antagonists: The Chelate Makes the Difference Melpomeni Fani, Luigi Del Pozzo, K. Abiraj, Journal of Nuclear Medicine	2011	255
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. Renzo Cescato, Stefan Schulz, Beatrice Waser, PubMed	2006	185
First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible Damian Wild, Melpomeni Fani, Martin Béhé, Journal of Nuclear Medicine	2011	178
Quantitative and Qualitative Intrapatient Comparison of <sup>68</sup>Ga-DOTATOC and <sup>68</sup>Ga-DOTATATE: Net Uptake Rate for Accurate Quantification Irina Velikyan, Anders Sundin, Jens Christian Hedemann Sørensen, Journal of Nuclear Medicine	2013	173
Unexpected Sensitivity of sst<sub>2</sub> Antagonists to N-Terminal Radiometal Modifications Melpomeni Fani, Friederike Braun, Beatrice Waser, Journal of Nuclear Medicine	2012	163
Sensitivity Comparison of <sup>68</sup>Ga-OPS202 and <sup>68</sup>Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study Guillaume Nicolas, N. Schreiter, Felix Kaul, Journal of Nuclear Medicine	2017	157
Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy Mengxin Xu, Pu Zhang, Jie Ding, Journal of Nuclear Medicine	2021	150
Identification and characterization of novel somatostatin antagonists. R T Bass, Brian L. Buckwalter, Bhai Patel, Molecular Pharmacology	1996	147

Page 1